Peptidyl-proline hydroxylation

pathway activity — cross-omics
GO:0019511Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-proline hydroxylation pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are TAF6, LRRC42, and P4HA1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-proline hydroxylation activity versus TAF6 in BRCA (Pearson r = 0.11).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCATAF6 →+0.360+0.154.008<.00134
LSCCLRRC42 →+0.383+0.165.004.00234
LSCCP4HA1 →+0.637+0.174<.001.00334
LSCCPDK1 →+0.366+0.105.001.00734
LSCCFRRS1 →+0.449+0.140.002.00434
LSCCSPATA33 →+0.346+0.148<.001.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0019511 vs TAF6 — BRCA

Per-sample scatter of Peptidyl-proline hydroxylation activity vs TAF6 in BRCA.

Explore this scatter interactively →

Exploration